Ionizing radiation produces a variety of damaging insults to nucleic acids, including the promutagenic lesion 8-hydroxydewyguanosine. In the present study, the 8-hydroxydeoxygunosine content of peripheral blood leukocyte DNA isolated from individuals exposed to therapeutic doses of ionizing radiation was determined by a HPLC-coupled 32p-postlabein assay. Peripheral blod leukocyte DNA from indivals rraited with 190-200 cGy were observed to contain 24.5 times as much 8-hydroxydeoxyguanosne as that from unexposed individuals. These results were confinmed by the use of a HPLC-coupled electrochemical detection system. Thus, human exposure to ionizing radiation significantly increased the circulating leukocyte DNA content of 8-hydrtydeoxyguanosine.
Introduction
Ionizing radiation, such as that used in radiation therapy, causes a wide variety of DNA damage, ranging from single-and double-strand breaks to DNA-protein cross-links, 8-hydroxydeoxyguanosine (8-OHdG), thymidine glycol, and other oxidative and free-radical damage (1) . Aside from single-strand breaks, 8 -OHdG appears to be the major adduction product of radiation damage to cellular DNA (1, 2) . This lesion, 8-OHdG, is known to be removed from DNA by repair mechanisms (3, 4) , which is not surprising considering that it is a promutagenic lesion (5, 6) . Thus, the ability to monitor individuals for 8-OHdG levels would be valuable to the assessment of DNA damage caused by ionizing radiation and other oxidative and free-radical inducing agents.
Techniques have recently been developed by us and others (3, (7) (8) (9) for the sensitive detection and quantitation of 8-OHdG residues in biological samples. This paper describes the quantitation of this oxidative DNA damage in circulating, nucleated blood cells in humans exposed to ionizing radiation by the use of
Methods and Results
Venous blood samples (7-10 mL) were collected in EDTAcoated vacutubes from untreated individuals and patients who just received a therapeutic dose ofionizing radiation. The blood was drawn within 45 min (between 15 and 45 min) ofcompletion of the radiation exposure, the buffy coat separated (between 15 min and 3 hr ofblood collection), and the DNA isolated by standard phenol extraction methods (9) . The phenol was freshly neutralized and buffered with 0.1 M Tris-HCI, pH 8.0, and 0.1% (3-hydroxyquinoline was added before use.
Postlabeling methods for 8-OHdG adduct analysis of DNA were developed by modifying our previously published methods (9) (10) (11) . Briefly, DNA samples (100 Ag) were enzymatically digested to deoxynucteotide-3 '-monophosphates (3 'dNMP) as previously described (9) (10) (11) , and then individually resolved by HPLC (Fig. 1) . The appropriate HPLC elution fractions for 3 'dGMP and 3 '8-OHdMP were separately pooled and onethousandth of the total unmodified 3'dGMP was added to the 3 '8-OHdGMP pooled fractions and lyophilized to dryness. The 3 '8-OHdGMP plus the 3 'dGMP were dissolved in sterile H20 and 32P-postlabeled as previously described (9-11), except that apyrase was replaced by ATPase (0.01-0.02 U) in the presence of 0.1 mM ZnSO4 and 0.1 mM of each K+, Mg+, and Cl1, and incubated at 37°C for 2 hr. The 32Pi was precipitated by the addition of cold (-4°C), concentrated formic acid and a freshly prepared solution of 400 mM Na tungstate/500 mM tetraethylammonium HCI/50 mM procaine and centrifuged for 10 min at 4°C. The supernatant was neutralized with the addition of 50% triethylamine/H20, lyophilized, reconstituted in sterile water, applied to prewashed PEI cellulose plates, and the nucleotides resolved by to4imensional TLC (Fig. 2) aValues represent the average or mean + SD of (n) samples.
described above, except that the procedure was performed under helium. Samples of DNA (100 ug) were enzymatically digested as described above. The digests were filtered through Millipore Ultrafree MC (10,000 molecular weight cutoff) filters and lyophilized to dryness. Each sample was dissolved in 30 yL of HPLC eluant and aliquots analyzed by HPLC with electrochemical detection. Samples were isocratically eluted with 20 mM sodium phosphate, pH 5.5 / 5 % MeOH, at a flow rate of 1.0 mL/min. Again, increased levels of 8-OHdG were observed in irradiated patients (Table 1) .
Discussion
The results indicate that people exposed to a therapeutic dose of ionizing radiation have higher levels of 8-OHdC in their circulating blood leukocyte DNA than nonirradiated individuals. HPLC/32P-postlabeling and TLC analysis of human peripheral blood DNA samples from exposed individuals showed between 2 and 4.4 times the content of this oxidative damage found in control samples. Similar increases in 8-OHdG levels in irradiated patients were also observed using electrochemical detection techniques. However, the basal level of 8-OHdG in circulating nucleated blood cells was approximately 5 times higher than previously suggested (3, 7, 8) . The protracted time frame of the DNA isolation, HPLC fractionation, postlabeling, and TLC procedures may have allowed excessive oxidation of the deoxyguanosine to have occurred, forming an abnormally high background.
Future studies ofpatients will require optimization ofconditions, both in the choice of patient (field ofexposure) and in the time frame of sample procurement and processing. First, the vascularity and the volume ofblood irradiated varies with tissue and tumor, so that the actual dose of radiation that peripheral blood cells receive may vary from person to person. Second, the pharmacokinetics of 8-OHdG formation and removal in circulating nucleated cells in humans following exposure to ionizing radiation is not known. Thus, the optimal time of sampling from patients needs to be discerned. And last, the optimal conditions and time frame for processing blood samples needs to be determined to avoid spurious increases in in vitro oxidative production of 8-OHdG.
